Cancentus
PrivateLast Round
Accelerator
Apr 14, 2026
Total Funding Raised
$560,000
Company Overview
Cancentus operates in Healthcare & Life Sciences and is based in Allschwil. Its latest recorded funding round was an Accelerator round in April 2026.
Cancentus is a biotechnology company that develops selective cancer therapies by exploiting oncogene-induced DNA replication stress, a key vulnerability unique to cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cancentus Comparables
Compare Cancentus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FoRx Therapeutics | 78% | |
| Artios Pharma | 76% | |
| Rakovina Therapeutics Inc. | 76% |
For institutional investors. Book with your work email.
Cancentus Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Cancentus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosuisse | Accelerator |
| BaseLaunch | Accelerator |
Cancentus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cancentus's valuation, stock price, and market status.
Is Cancentus a public or private company?
Cancentus is a private company.
What is the current stock price of Cancentus?
Cancentus is a private company, so its shares have no public market price. Caplight tracks Cancentus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cancentus worth (valuation)?
Valuation information for Cancentus is not publicly available.
Can I buy Cancentus stock?
Cancentus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cancentus's last funding round?
Cancentus's most recent funding round was Accelerator on April 14, 2026.
Who are the main investors in Cancentus?
Key investors in Cancentus include BaseLaunch.
Will Cancentus IPO soon?
No public IPO plans have been announced for Cancentus.
How can I track Cancentus secondary market activity?
Caplight tracks bids, offers, and trades in Cancentus's shares on secondary markets.